Natural autoantibodies to the gonadotropin-releasing hormone receptor in polycystic ovarian syndrome

LM Sattler, HA Schniewind, WB Minich, CW Haudum… - Plos one, 2021 - journals.plos.org
Context Polycystic ovarian syndrome (PCOS) is a complex disease with different subtypes
and unclear etiology. Among the frequent comorbidities are autoimmune diseases …

Metformin with or without clomiphene citrate versus laparoscopic ovarian drilling with or without clomiphene citrate to treat patients with clomiphene citrate-resistant …

ML Sun, WP Bai, QK Song, HY Wang… - Frontiers in …, 2022 - frontiersin.org
Introduction: Which is optimal to treat clomiphene citrate-resistant polycystic ovary syndrome
(CCR-PCOS) with LOD or metformin remains a problem. There are three inconsistent or …

Polycystic ovary syndrome: Insights into its prevalence, diagnosis, and management with special reference to gut microbial dysbiosis

NH Khobragade, DB Sheth, CA Patel, JV Beladiya… - Steroids, 2024 - Elsevier
Polycystic ovary syndrome (PCOS) represents major endocrine and metabolic disorder
among women largely characterized by hyperandrogenism and oligomenorrhea precipitates …

Cardiovascular Disease in Hispanic Women: JACC Review Topic of the Week

O Quesada, D Crousillat, F Rodriguez… - Journal of the American …, 2024 - jacc.org
Cardiovascular disease affects 37% of Hispanic women and is the leading cause of death
among Hispanic women in the United States. Hispanic women have a higher burden of …

PCOS health-related quality-of-life and depressive symptoms across the lifespan: comparative study

PJ Wright, AS Tavakoli, CF Corbett - Journal of Women & Aging, 2024 - Taylor & Francis
The purpose of this cross-sectional study was to compare health-related quality of life
(HRQoL) and depressive symptoms among peri-postmenopausal women with polycystic …

Deciphering the DNA methylome of polycystic ovary syndrome

Q Tan - Molecular Diagnosis & Therapy, 2020 - Springer
Polycystic ovary syndrome (PCOS) is a hormonal disorder common among women of
reproductive age. PCOS is characterized by ovarian dysfunction and metabolic …

Distribution of lipid levels and prevalence of hyperlipidemia: data from the NHANES 2007–2018

Z Li, G Zhu, G Chen, M Luo, X Liu, Z Chen… - Lipids in Health and …, 2022 - Springer
Background Lipid-lowering therapy is important, and the distribution of lipid levels and the
incidence of hyperlipidemia may vary in different subgroups of the population. We aimed to …

Yishen Huatan Huoxue decoction and quercetin ameliorate decidualization dysfunction in polycystic ovary syndrome: A comprehensive investigation combining …

J Wang, L Li, J Zhou, X Pan, Q Qi, H Sun… - Drug Discoveries & …, 2024 - jstage.jst.go.jp
Polycystic ovary syndrome (PCOS) is a common gynecological endocrine disorder
characterized by a complex pathogenesis and limited treatment options. Yishen Huatan and …

A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database

L Liu - Frontiers in Pharmacology, 2024 - frontiersin.org
Background Tirzepatide, a glucose-dependent insulinotropic polypeptide (GIP) receptor and
glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight …

Correlation of self-reported racial background to euploidy status and live birth rates in assisted reproductive technology cycles

T Alkon-Meadows, C Hernandez-Nieto… - Journal of Assisted …, 2024 - Springer
Purpose To determine whether the embryonic euploidy rate and live birth outcomes
following single, euploid embryo transfer (SEET) differ among women of self-reported racial …